Abstract
In 2019, a new viral disease, known as SARS-Cov-2 infection, was identified. Scientists believed that it was a disease with low morbidity for pediatric patients; however, a small percentage of children infected with the new coronavirus developed a multisystem inflammatory response, which aroused the interest of many researchers and health professionals. The objective of the study is to describe the main characteristics related to the Pediatric Multisystemic Inflammatory Syndrome Associated with Covid-19 (MIS-C), its complications and nursing care. The main clinical manifestations of MIS-C are hyperthermia, gastrointestinal symptoms, skin manifestations, generalized lymphadenopathy, cardiac and neurological disorders. The main nursing care was listed according to the signs and symptoms, such as monitoring of neurological and hydroelectrolytic changes. The nurse professional must add knowledge about MIS-C so that he is able to qualify his care and improve his skills to provide quality care to pediatric patients.
Publisher
Revista Ciencias em Saude
Reference23 articles.
1. Campos L, Cardoso T, Martinez J, Almeida R, Silva R, Fonseca A, et al. Pediatric inflammatory multisystem syndrome (PIMS) temporally related to SARS-CoV-2. Resid Pediatr. 2020;10(2):1-6. https://doi.org/10.25060/residpediatr-2020.v10n2-348
2. Brasil, Ministério da Saúde, Universidade Federal do Rio Grande do Sul. Síndrome Inflamatória Multissistêmica Pediátrica (SIM-P): Associada à Covid-19. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2020. 12 p. Available from: https://bit.ly/3ibaTP8
3. Brasil, Ministério da Saúde. Guia de Vigilância Epidemiológica. Versão 3. 2021 Mar 15 [cited 2021 May 21]. Avaiable from: https://bit.ly/2RCxdXd
4. Nakra NA, Blumberg DA, Herrera-Guerra A, Lakshminrusimha S. Multi-System Inflammatory Syndrome in Children (MIS-C) following SARS-CoV-2 infection: review of clinical presentation, hypothetical pathogenesis, and proposed management. Children (Basel). 2020;7(7):69. https://doi.org/10.3390/children7070069 PMid:32630212 PMCid:PMC7401880
5. Brasil, Ministério da Saúde, Secretaria de Vigilância em Saúde. Boletim Epidemiológico Especial 52. Brasilia, DF: Ministério da Saúde; 2021 Mar 4 [cited 2021 May 23]. Avaiable from: https://bit.ly/3fDIChj